QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL01 ANTINEOPLASTIC AGENTS
QL01X OTHER ANTINEOPLASTIC AGENTS
QL01XE Protein kinase inhibitors
QL01XE91 toceranib
Last updated: 2019-12-19
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer